| Product Code: ETC7764746 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Myasthenia Gravis Disease Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Myasthenia Gravis Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Myasthenia Gravis Disease Market - Industry Life Cycle |
3.4 Jordan Myasthenia Gravis Disease Market - Porter's Five Forces |
3.5 Jordan Myasthenia Gravis Disease Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Jordan Myasthenia Gravis Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Jordan Myasthenia Gravis Disease Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 Jordan Myasthenia Gravis Disease Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.9 Jordan Myasthenia Gravis Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Jordan Myasthenia Gravis Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of myasthenia gravis in Jordan |
4.2.2 Advancements in diagnostic technologies and treatment options |
4.2.3 Rising awareness and early diagnosis initiatives |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in certain regions of Jordan |
4.3.2 High cost of treatment and medication for myasthenia gravis patients |
4.3.3 Lack of trained healthcare professionals and specialists in managing the disease |
5 Jordan Myasthenia Gravis Disease Market Trends |
6 Jordan Myasthenia Gravis Disease Market, By Types |
6.1 Jordan Myasthenia Gravis Disease Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Edrophonium Test, 2021- 2031F |
6.1.4 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.1.5 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Repetitive Nerve Stimulation, 2021- 2031F |
6.1.6 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Single-fiber electromyography (EMG), 2021- 2031F |
6.1.7 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Jordan Myasthenia Gravis Disease Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F |
6.2.3 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.2.4 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Immunosuppressants, 2021- 2031F |
6.2.5 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Plasmapheresis, 2021- 2031F |
6.2.6 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Autologous Hematopoietic Stem Cell Transplantation (HSCT), 2021- 2031F |
6.2.7 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3 Jordan Myasthenia Gravis Disease Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Jordan Myasthenia Gravis Disease Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Jordan Myasthenia Gravis Disease Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Onlin Pharmacy, 2021- 2031F |
6.5.4 Jordan Myasthenia Gravis Disease Market Revenues & Volume, By Retail Phrmacy, 2021- 2031F |
7 Jordan Myasthenia Gravis Disease Market Import-Export Trade Statistics |
7.1 Jordan Myasthenia Gravis Disease Market Export to Major Countries |
7.2 Jordan Myasthenia Gravis Disease Market Imports from Major Countries |
8 Jordan Myasthenia Gravis Disease Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for myasthenia gravis patients in Jordan |
8.2 Percentage of myasthenia gravis patients receiving timely and appropriate treatment |
8.3 Number of awareness campaigns and educational programs conducted annually for myasthenia gravis in Jordan |
8.4 Rate of adherence to treatment plans among myasthenia gravis patients |
9 Jordan Myasthenia Gravis Disease Market - Opportunity Assessment |
9.1 Jordan Myasthenia Gravis Disease Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Jordan Myasthenia Gravis Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Jordan Myasthenia Gravis Disease Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 Jordan Myasthenia Gravis Disease Market Opportunity Assessment, By End users, 2021 & 2031F |
9.5 Jordan Myasthenia Gravis Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Jordan Myasthenia Gravis Disease Market - Competitive Landscape |
10.1 Jordan Myasthenia Gravis Disease Market Revenue Share, By Companies, 2024 |
10.2 Jordan Myasthenia Gravis Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here